Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Moody's Corporation (MCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Moody's Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Moody's Corporation trades at $467 (market cap $80.14B). The key difference: Moody's Corporation is far larger — about 2.6× GE HealthCare Technologies Inc. Common Stock's market cap, and Moody's Corporation pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| GEHC | MCO | |
|---|---|---|
Market Cap | $30.93B | $80.14B |
Volume | 5,033,451 | 829,155 |
Sector | Health | Financials |
52-Week High | $88.16 | $539.61 |
52-Week Low | $59.48 | $412.23 |
Enterprise Value | $39.39B | $86.17B |
Dividend Yield | 0.23% | 0.89% |
Typical Hold Time | — | 133 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
MCO trades at $464.13, down 1.35% today, but maintains a bullish technical outlook with strong support at $464. Revenue grew to $7.72B in 2025 with a net income margin of 34.25%, and the company has beaten earnings estimates for three consecutive quarters. Recent news highlights strategic moves like a minority stake in PhilRatings to bolster Asia-Pacific presence and a top RiskTech100 ranking for the fifth year.
The outlook remains positive with a consensus price target of $536.40, implying 15.6% upside, supported by robust profitability and growth initiatives. Key risks include high valuation multiples and exposure to economic cycles affecting credit demand. Analyst sentiment is predominantly bullish with 18 buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →
